Turning Point Brands

Q2 FY2026 EarningsQ2 FY2026 results showed a top-line beat with revenue of $143.0M vs. $129.6M expected, driven by a 128% surge in Modern Oral net sales. However, significant investments in sales and marketing led to a miss in profitability, with Adjusted Diluted EPS of $0.23 slightly trailing the $0.238 consensus. Management raised FY26 Modern Oral net sales guidance to $260-270M, though Adjusted EBITDA guidance remains modest at $70-90M due to ongoing strategic spending.